Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Hereditary palmoplantar keratoderma, Gamborg-Nielsen type is characterized by the presence of diffuse palmoplantar keratoderma without associated symptoms. The syndrome has been described in multiple families from the northernmost county of Sweden (Norrbotten). The palmoplantar keratoderma found in the Gamborg-Nielsen type disease is milder than that found in Mal de Meleda but more severe than that found in Thost-Unna palmoplantar keratoderma. Transmission is autosomal recessive.
Biomarker and diagnostic research for hereditary palmoplantar keratoderma, Gamborg-Nielsen type has been reported in the published literature.
No clinical trials have been registered for hereditary palmoplantar keratoderma, Gamborg-Nielsen type.
118 publications have been identified in PubMed for hereditary palmoplantar keratoderma, Gamborg-Nielsen type. Research spans Case Report / Case Series (42%), Review / Meta-Analysis (22%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 49 | 42% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 4:39 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
26 |
22% |
Laboratory research | 18 | 15% |
Other research | 11 | 9% |
New treatment approaches | 8 | 7% |
Disease patterns and progression | 5 | 4% |
Testing and diagnosis research | 1 | 1% |
Greiling TM (2026). [PMID: 29494043](https://pubmed.ncbi.nlm.nih.gov/29494043/). *Unknown Journal*. [Case Report / Case Series]
Lazarowitz R (2026). [PMID: 42104829](https://pubmed.ncbi.nlm.nih.gov/42104829/). *J Cutan Med Surg*. [Other]
Xiao Z (2026). [PMID: 42125668](https://pubmed.ncbi.nlm.nih.gov/42125668/). *Front Immunol*. [Review / Meta-Analysis]
Alibrahim L (2026). [PMID: 41755622](https://pubmed.ncbi.nlm.nih.gov/41755622/). *Dermatol Reports*. [Gene Therapy / Novel Therapeutics]
Chua Y (2026). [PMID: 41798155](https://pubmed.ncbi.nlm.nih.gov/41798155/). *JAAD Case Rep*. [Case Report / Case Series]
Brandt E (2026). [PMID: 40899407](https://pubmed.ncbi.nlm.nih.gov/40899407/). *J Eur Acad Dermatol Venereol*. [Other]
Jiang X (2026). [PMID: 41533385](https://pubmed.ncbi.nlm.nih.gov/41533385/). *JAMA Dermatol*. [Case Report / Case Series]
Cohen E (2026). [PMID: 41950305](https://pubmed.ncbi.nlm.nih.gov/41950305/). *Sci Transl Med*. [Basic Science / Preclinical]
Ceccacci S (2026). [PMID: 41581590](https://pubmed.ncbi.nlm.nih.gov/41581590/). *J Invest Dermatol*. [Basic Science / Preclinical]
Peh JT (2026). [PMID: 42034525](https://pubmed.ncbi.nlm.nih.gov/42034525/). *J Dermatol Sci*. [Gene Therapy / Novel Therapeutics]